Comments
Loading...
Stime degli utili, EPS e fatturato
Nurix Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
ott 17
Stima EPS
$-0.850
Stima dei ricavi trimestrali
$17.10M
Ricavi annuali
(a partire da mag 31)
(a partire da mag 31)
$88.38M
Analizza lo storico degli utili di Nurix Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
NRIX | Nurix Therapeutics | -$0.67 | -$0.85 | — | — | $12.59M | $17.10M | — | — | 10/17/2025 | |
NRIX | Nurix Therapeutics | -$0.71 | -$0.75 | -$0.52 | 30.67% | $12.09M | $16.89M | $44.06M | 160.84% | 07/09/2025 | |
NRIX | Nurix Therapeutics | -$0.76 | -$0.78 | -$0.67 | 14.10% | $16.59M | $12.71M | $18.45M | 45.18% | 04/08/2025 | |
NRIX | Nurix Therapeutics | -$0.77 | -$0.71 | -$0.75 | -5.63% | $15.16M | $12.86M | $13.28M | 3.31% | 01/28/2025 | |
NRIX | Nurix Therapeutics | -$0.68 | -$0.72 | -$0.67 | 6.94% | $18.47M | $15.76M | $12.59M | -20.13% | 10/11/2024 | |
NRIX | Nurix Therapeutics | -$0.45 | -$0.64 | -$0.71 | -10.94% | $30.68M | $22.89M | $12.09M | -47.17% | 07/11/2024 | |
NRIX | Nurix Therapeutics | -$0.75 | -$0.80 | -$0.76 | 5.00% | $12.69M | $16.64M | $16.59M | -0.33% | 04/10/2024 | |
NRIX | Nurix Therapeutics | -$0.87 | -$0.57 | -$0.77 | -35.09% | $6.78M | $22.26M | $15.16M | -31.90% | 02/15/2024 | |
NRIX | Nurix Therapeutics | -$0.90 | -$0.76 | -$0.68 | 10.53% | $10.79M | $17.23M | $18.47M | 7.18% | 10/12/2023 | |
NRIX | Nurix Therapeutics | -$1.01 | -$0.56 | -$0.45 | 19.64% | $11.43M | $26.21M | $30.68M | 17.04% | 07/13/2023 | |
NRIX | Nurix Therapeutics | -$0.95 | -$0.87 | -$0.75 | 13.79% | $9.62M | $10.87M | $12.69M | 16.70% | 04/13/2023 | |
NRIX | Nurix Therapeutics | -$0.85 | -$0.79 | -$0.87 | -10.13% | $7.40M | $17.17M | $6.78M | -60.50% | 02/09/2023 | |
NRIX | Nurix Therapeutics | -$0.65 | -$0.98 | -$0.90 | 8.16% | $10.25M | $12.08M | $10.79M | -10.67% | 10/06/2022 | |
NRIX | Nurix Therapeutics | -$0.60 | -$0.99 | -$1.01 | -2.02% | $7.09M | $10.50M | $11.43M | 8.88% | 07/07/2022 | |
NRIX | Nurix Therapeutics | -$0.63 | -$0.88 | -$0.95 | -7.95% | $5.01M | $9.27M | $9.62M | 3.79% | 04/07/2022 | |
NRIX | Nurix Therapeutics | -$0.51 | -$0.69 | -$0.85 | -23.19% | $6.69M | $13.19M | $7.40M | -43.93% | 01/27/2022 | |
NRIX | Nurix Therapeutics | -$1.09 | -$0.62 | -$0.65 | -4.84% | $4.08M | $8.57M | $10.25M | 19.63% | 10/14/2021 | |
NRIX | Nurix Therapeutics | — | -$0.54 | -$0.60 | -11.11% | $4.18M | $8.23M | $7.09M | -13.84% | 07/13/2021 | |
NRIX | Nurix Therapeutics | — | -$0.46 | -$0.63 | -36.96% | — | $7.94M | $5.01M | -36.89% | 04/13/2021 | |
NRIX | Nurix Therapeutics | -$3.55 | -$0.54 | -$0.51 | 5.56% | — | $3.94M | $6.69M | 69.77% | 02/16/2021 | |
NRIX | Nurix Therapeutics | -$0.66 | -$0.41 | -$0.59 | -43.90% | $10.58M | $6.34M | $4.08M | -35.57% | 10/14/2020 |
Nurix Therapeutics (NRIX) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-07-09 | $-0.52 | $-0.75 | 30.7 % |
| Q1 | 2025-04-08 | $-0.67 | $-0.78 | 14.1 % |
| Q4 | 2025-01-28 | $-0.75 | $-0.71 | -5.63 % |
| Q3 | 2024-10-11 | $-0.67 | $-0.72 | 6.94 % |
Nurix Therapeutics (NRIX) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-07-09 | $44.06M | $16.89M | 160.8 % |
| Q1 | 2025-04-08 | $18.45M | $12.71M | 45.2 % |
| Q4 | 2025-01-28 | $13.28M | $12.86M | 3.31 % |
| Q3 | 2024-10-11 | $12.59M | $15.76M | -20.1 % |
FAQ
Quando Nurix Therapeutics (NASDAQ:NRIX) riporterà gli utili?
Si prevede che Nurix Therapeutics (NRIX) fornisca risultati il ottobre 17, 2025. Gli ultimi risultati sono stati pubblicati il luglio 9, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Nurix Therapeutics (NASDAQ:NRIX)?
L'EPS effettivo era $-0.52, che superato la stima di $-0.75.
Quali sono state le entrate di Nurix Therapeutics (NASDAQ:NRIX)?
Le entrate effettive sono state $44.1M, che superato la stima di $16.9M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.